Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies
Similar Posts
Scientific Protein Laboratories, LLC – 712578 – 10/10/2025
CGMP/Active Pharmaceutical Ingredient (API)/AdulteratedErosive Esophagitis: Developing Drugs for Treatment
Erosive Esophagitis: Developing Drugs for TreatmentCompounding Quality Center of Excellence | Engage with the Compounding Quality Center of Excellence
Engage with the Compounding Quality Center of ExcellenceCommissioner’s National Priority Voucher (CNPV) Pilot Program
FDA Commissioner’s National Priority Voucher Program. The Commissioner’s National Priority Voucher Program offers an unprecedented opportunity to reduce drug and biologic review times from 10-12 months to just 1-2 months.RIGIDRX may be harmful due to hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use RIGIDRX, a product promoted and sold for sexual enhancement on various websites and possibly in some retail stores.FDA warns consumers not to use counterfeit Ozempic (semaglutide) found in U.S. drug supply chain
FDA continues to investigate counterfeit Ozempic (semaglutide) injection 1 milligram (mg) in the legitimate U.S. drug supply chain and has seized thousands of units of the product. The agency advises wholesalers, retail pharmacies, health care practitioners and patients to check the pro